Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BXU-001 by Baylx for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
BXU-001 is under clinical development by Baylx and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase...